TREM2 signalling transduction has a central role in promoting microglial activation (11) and variants in TREM2 have been linked to different types of neurological diseases, including multiple sclerosis, Parkinson’s and Alzheimer’s diseases (58–62). Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.